T-knife Therapeutics’ $110 Million Series B Financing

Fenwick & West advised T-knife Therapeutics on the deal. Torys LLP acted as counsel to Sixty Degree Capital. T-knife Therapeutics, Inc., a next-generation T-cell receptor company…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here